Myeloid myeloid PRDM16 restrains macrophage inflammatory remodeling and renal fibrosis in diabetic kidney disease by limiting PI3K/AKT activation
Acta Diabetologica · 28.08.2026 · 63 (12) · 2081-2096
DOI: 10.1007/s00592-026-02779-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Diabetologica, erschienen am 28.08.2026. Verfasst von Shanshan Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Anhui No. 2 Provincial People's Hospital, 1868 Dangshan Road, North Second Ring, Hefei, 230041, Anhui Province, P. R. Ch…. Hauptthemen laut MEDLINE: Phosphatidylinositol 3-Kinases, Macrophages, Diabetic Nephropathies, Proto-Oncogene Proteins c-akt. Die Arbeit nennt 32 Literaturangaben. Gefördert von: the Natural Science Research Project of Colleges and Universities in Anhui Province.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, Anhui No. 2 Provincial People's Hospital, 1868 Dangshan Road, North Second Ring, Hefei, 230041, Anhui Province, P. R. China. 19965193897@163.com.
- Department of Graduate, Bengbu Medical University, Bengbu, 233030, Anhui, China.
Förderung
- the Natural Science Research Project of Colleges and Universities in Anhui Province
Zitieren
APA
Wang, S., Zhang, T., & He, M. (2026). Myeloid myeloid PRDM16 restrains macrophage inflammatory remodeling and renal fibrosis in diabetic kidney disease by limiting PI3K/AKT activation. Acta Diabetologica. https://doi.org/10.1007/s00592-026-02779-1
Vancouver
Wang S, Zhang T, He M. Myeloid myeloid PRDM16 restrains macrophage inflammatory remodeling and renal fibrosis in diabetic kidney disease by limiting PI3K/AKT activation. Acta Diabetologica. 2026. doi:10.1007/s00592-026-02779-1
BibTeX
@article{Wang2026,
author = {Wang, Shanshan and Zhang, Tao and He, Miao},
title = {Myeloid myeloid PRDM16 restrains macrophage inflammatory remodeling and renal fibrosis in diabetic kidney disease by limiting PI3K/AKT activation},
journal = {Acta Diabetologica},
year = {2026},
doi = {10.1007/s00592-026-02779-1}
}
EUVIMED